Safe Zone in Trigger Point Injection
ConditionTrigger Point Pain, Myofascial
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAnkara University
About this trial
The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question\[s\] it aims to answer \[is/are\]:
The mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation
Eligibility criteria
Qualifiers
patients diagnosed with Myofascial Pain Syndrome
patients scheduled for trigger point injections due to Myofascial Pain Syndrome.
Disqualifiers
under 18 years of age,
additional diseases other than Myofascial Pain Syndrome,
the presence of active infection in the interscapular area where ultrasound imaging and measurements will be performed,
lesions that disrupt skin integrity or affect subcutaneous and muscle structures such as anomalies or masses that could impair imaging quality
Trial design
Treatments tested in this trial
- Ultrasound guided injection with local anaestethic
- Ultrasound guided injection with local anaestethic
Treatment groups
211 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov